(410 ILCS 620/14) (from Ch. 56 1/2, par. 514)
Sec. 14.
A drug or device is adulterated:
(a) (1) If it consists in
whole or in part of any filthy, putrid or
decomposed substance; or (2) (A) if it has been produced, prepared, packed
or held under unsanitary conditions whereby it may have been contaminated
with filth or whereby it may have been rendered injurious to health; or (B)
if it is a drug and the methods used in, or the facilities or controls used
for, its manufacture, processing, packing or holding do not conform to or
are not operated or administered in conformity with current good
manufacturing practice to assure that such drug meets the requirements of
the Act as to safety and has the identity and strength and meets the
quality and purity characteristics which it purports or is represented to
possess; or (3) if it is a drug and its container is composed, in whole or
in part, of any poisonous or deleterious substance which may render the
contents injurious to health; or (4) if (A) it is a drug and it bears or
contains, for purposes of coloring only, a color additive which is unsafe
within the meaning of Section 706 of the Federal Act or (B) it is a
color additive, the intended use of which in or on drugs or devices is
for purposes of coloring only and
is unsafe within the meaning of Section 706 of the Federal Act; or
(5) if it is a new animal drug which is unsafe within the meaning of Section
512 of the Federal Act; or (6) if it is an animal feed bearing or
containing a new animal drug, and such animal feed is unsafe within the
meaning of Section 512 of the Federal Act.
(b) If it purports to be or is represented as a drug the name of which
is recognized in an official compendium, and its strength differs from or
its quality or purity falls below the standard set forth in such
compendium. Such determination as to strength, quality or purity shall be
made in accordance with the tests or methods of assay set forth in such
compendium or in the absence of or inadequacy of such tests or methods of
assay, those prescribed under authority of the Federal Act. No drug defined
in an official compendium is adulterated under this subsection because it
differs from the standard of strength, quality or purity therefor set forth
in such compendium, if its difference in strength, quality or purity from
such standard is plainly stated on its label. When a drug is recognized in
both the United States Pharmacopoeia - National Formulary and the Homeopathic
Pharmacopoeia of
the United States it shall be subject to the requirements of the United
States Pharmacopoeia - National Formulary unless it is labeled and offered
for sale as a
homeopathic drug, in which case it shall be subject to the provisions of
the Homeopathic Pharmacopoeia of the United States and not to those of the
United States Pharmacopoeia - National Formulary.
(c) If it is not subject to the provisions of subsection (b) of this
Section and its strength differs from or its purity or quality falls below
that which it purports or is represented to possess.
(d) If it is a drug and any substance has been (1) mixed or packed
therewith so as to reduce its quality or strength; or (2) substituted
wholly or in part therefor.
(e) If it is, or purports to be or is represented as, a device which
is subject to a performance standard established under Section 514 of the
Federal Act, unless such device is in all respects in conformity with such standard.
(f) If it is a device and the methods used in, or the facilities or controls
used for, its manufacture, packing, storage, or installations are not in
conformity with applicable requirements under Section 520(b)(1) of the Federal
Act or an applicable condition as prescribed by an order under Section 520(b)(2)
of the Federal Act.
(g) If it is a device for which an exemption has been granted under Section
520(g) of the Federal Act for investigational use and the person who was
granted such exemption fails to comply with a requirement prescribed by
or under such Section.
(Source: P.A. 84-891.)
|